Third Rock Ventures GP IV, L.P., 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 1,100,342 shares at $9.79 ($10.8M) on 2024-07-17, disclosed to the SEC on 2024-07-18.
Open-market sale of $10.8M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.79 | 550,171 | $5.4M | 50.0% |
| 2 | $9.79 | 550,171 | $5.4M | 50.0% |
| Total | $9.79 avg | 1,100,342 | $10.8M | 100% |
| Filing → |
| TNGX | SELL | 2024-08-20 | $2.8M | — | Filing → |
| TNGX | SELL | 2024-08-01 | $3.2M | — | Filing → |
| TNGX | SELL | 2024-07-24 | $6.4M | — | Filing → |